nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—CXCL8—ovarian cancer	0.514	1	CbGaD
Ketoprofen—SLCO1A2—Chlorambucil—ovarian cancer	0.153	0.63	CbGbCtD
Ketoprofen—SLC22A7—Docetaxel—ovarian cancer	0.0542	0.223	CbGbCtD
Ketoprofen—CYP2C8—Paclitaxel—ovarian cancer	0.021	0.0864	CbGbCtD
Ketoprofen—CYP2C9—Paclitaxel—ovarian cancer	0.0146	0.0602	CbGbCtD
Ketoprofen—PTGS2—ovarian follicle—ovarian cancer	0.00419	0.103	CbGeAlD
Ketoprofen—CXCR1—bone marrow—ovarian cancer	0.00345	0.0849	CbGeAlD
Ketoprofen—CXCL8—myometrium—ovarian cancer	0.00222	0.0547	CbGeAlD
Ketoprofen—CXCR1—lymph node—ovarian cancer	0.00213	0.0526	CbGeAlD
Ketoprofen—PTGS1—oviduct—ovarian cancer	0.00193	0.0474	CbGeAlD
Ketoprofen—CXCL8—uterine cervix—ovarian cancer	0.00173	0.0426	CbGeAlD
Ketoprofen—CXCL8—decidua—ovarian cancer	0.00165	0.0406	CbGeAlD
Ketoprofen—CXCL8—endometrium—ovarian cancer	0.00156	0.0385	CbGeAlD
Ketoprofen—CXCL8—bone marrow—ovarian cancer	0.00122	0.0301	CbGeAlD
Ketoprofen—CXCL8—female gonad—ovarian cancer	0.00118	0.029	CbGeAlD
Ketoprofen—CXCL8—vagina—ovarian cancer	0.00117	0.0288	CbGeAlD
Ketoprofen—SLC22A11—female reproductive system—ovarian cancer	0.00107	0.0264	CbGeAlD
Ketoprofen—CXCL8—testis—ovarian cancer	0.00105	0.0257	CbGeAlD
Ketoprofen—SLC22A7—testis—ovarian cancer	0.000845	0.0208	CbGeAlD
Ketoprofen—CXCL8—lymph node—ovarian cancer	0.000757	0.0187	CbGeAlD
Ketoprofen—ABCC4—uterus—ovarian cancer	0.000679	0.0167	CbGeAlD
Ketoprofen—ABCC4—female reproductive system—ovarian cancer	0.00061	0.015	CbGeAlD
Ketoprofen—PTGS2—myometrium—ovarian cancer	0.000589	0.0145	CbGeAlD
Ketoprofen—ABCC4—bone marrow—ovarian cancer	0.000576	0.0142	CbGeAlD
Ketoprofen—PTGS2—embryo—ovarian cancer	0.000566	0.0139	CbGeAlD
Ketoprofen—ABCC4—female gonad—ovarian cancer	0.000555	0.0137	CbGeAlD
Ketoprofen—CYP2C8—endometrium—ovarian cancer	0.000535	0.0132	CbGeAlD
Ketoprofen—SLCO1A2—testis—ovarian cancer	0.000512	0.0126	CbGeAlD
Ketoprofen—ALB—testis—ovarian cancer	0.000509	0.0125	CbGeAlD
Ketoprofen—ABCC4—testis—ovarian cancer	0.000492	0.0121	CbGeAlD
Ketoprofen—PTGS1—epithelium—ovarian cancer	0.000484	0.0119	CbGeAlD
Ketoprofen—PTGS1—uterine cervix—ovarian cancer	0.000479	0.0118	CbGeAlD
Ketoprofen—PTGS2—epithelium—ovarian cancer	0.000462	0.0114	CbGeAlD
Ketoprofen—PTGS2—uterine cervix—ovarian cancer	0.000458	0.0113	CbGeAlD
Ketoprofen—CYP2C8—female reproductive system—ovarian cancer	0.000443	0.0109	CbGeAlD
Ketoprofen—PTGS1—endometrium—ovarian cancer	0.000434	0.0107	CbGeAlD
Ketoprofen—PTGS2—endometrium—ovarian cancer	0.000414	0.0102	CbGeAlD
Ketoprofen—CYP2C8—vagina—ovarian cancer	0.000401	0.00987	CbGeAlD
Ketoprofen—PTGS1—uterus—ovarian cancer	0.0004	0.00984	CbGeAlD
Ketoprofen—CYP2C9—female reproductive system—ovarian cancer	0.000393	0.00969	CbGeAlD
Ketoprofen—PTGS2—uterus—ovarian cancer	0.000382	0.00941	CbGeAlD
Ketoprofen—ALB—lymph node—ovarian cancer	0.000369	0.00908	CbGeAlD
Ketoprofen—PTGS1—female reproductive system—ovarian cancer	0.000359	0.00885	CbGeAlD
Ketoprofen—CYP2C8—testis—ovarian cancer	0.000357	0.0088	CbGeAlD
Ketoprofen—ABCC4—lymph node—ovarian cancer	0.000357	0.00879	CbGeAlD
Ketoprofen—PTGS2—female reproductive system—ovarian cancer	0.000343	0.00846	CbGeAlD
Ketoprofen—PTGS1—female gonad—ovarian cancer	0.000327	0.00805	CbGeAlD
Ketoprofen—PTGS1—vagina—ovarian cancer	0.000325	0.008	CbGeAlD
Ketoprofen—PTGS2—bone marrow—ovarian cancer	0.000324	0.00798	CbGeAlD
Ketoprofen—PTGS2—female gonad—ovarian cancer	0.000312	0.00769	CbGeAlD
Ketoprofen—PTGS2—vagina—ovarian cancer	0.000311	0.00765	CbGeAlD
Ketoprofen—PTGS1—testis—ovarian cancer	0.00029	0.00714	CbGeAlD
Ketoprofen—PTGS1—lymph node—ovarian cancer	0.00021	0.00518	CbGeAlD
Ketoprofen—PTGS2—lymph node—ovarian cancer	0.000201	0.00495	CbGeAlD
Ketoprofen—Rash—Melphalan—ovarian cancer	0.00015	0.00102	CcSEcCtD
Ketoprofen—Dermatitis—Melphalan—ovarian cancer	0.00015	0.00102	CcSEcCtD
Ketoprofen—Chills—Docetaxel—ovarian cancer	0.00015	0.00102	CcSEcCtD
Ketoprofen—Asthenia—Vinorelbine—ovarian cancer	0.000149	0.00102	CcSEcCtD
Ketoprofen—Arrhythmia—Docetaxel—ovarian cancer	0.000149	0.00102	CcSEcCtD
Ketoprofen—Abdominal pain upper—Epirubicin—ovarian cancer	0.000148	0.00101	CcSEcCtD
Ketoprofen—Convulsion—Paclitaxel—ovarian cancer	0.000148	0.00101	CcSEcCtD
Ketoprofen—Migraine—Doxorubicin—ovarian cancer	0.000148	0.00101	CcSEcCtD
Ketoprofen—Hypertension—Paclitaxel—ovarian cancer	0.000148	0.00101	CcSEcCtD
Ketoprofen—Alopecia—Docetaxel—ovarian cancer	0.000147	0.001	CcSEcCtD
Ketoprofen—Pruritus—Vinorelbine—ovarian cancer	0.000147	0.001	CcSEcCtD
Ketoprofen—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000146	0.000998	CcSEcCtD
Ketoprofen—Myalgia—Paclitaxel—ovarian cancer	0.000146	0.000994	CcSEcCtD
Ketoprofen—Anxiety—Paclitaxel—ovarian cancer	0.000145	0.00099	CcSEcCtD
Ketoprofen—Face oedema—Doxorubicin—ovarian cancer	0.000145	0.00099	CcSEcCtD
Ketoprofen—Erythema—Docetaxel—ovarian cancer	0.000145	0.000989	CcSEcCtD
Ketoprofen—Nausea—Topotecan—ovarian cancer	0.000144	0.000983	CcSEcCtD
Ketoprofen—Discomfort—Paclitaxel—ovarian cancer	0.000144	0.000982	CcSEcCtD
Ketoprofen—Gastritis—Epirubicin—ovarian cancer	0.000144	0.000981	CcSEcCtD
Ketoprofen—Dry mouth—Paclitaxel—ovarian cancer	0.000143	0.000972	CcSEcCtD
Ketoprofen—Diarrhoea—Vinorelbine—ovarian cancer	0.000142	0.000969	CcSEcCtD
Ketoprofen—Dysgeusia—Docetaxel—ovarian cancer	0.000142	0.000969	CcSEcCtD
Ketoprofen—Nausea—Melphalan—ovarian cancer	0.000141	0.000963	CcSEcCtD
Ketoprofen—Confusional state—Paclitaxel—ovarian cancer	0.000141	0.00096	CcSEcCtD
Ketoprofen—Asthma—Epirubicin—ovarian cancer	0.00014	0.000958	CcSEcCtD
Ketoprofen—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00014	0.000953	CcSEcCtD
Ketoprofen—Oedema—Paclitaxel—ovarian cancer	0.00014	0.000953	CcSEcCtD
Ketoprofen—Infection—Paclitaxel—ovarian cancer	0.000139	0.000946	CcSEcCtD
Ketoprofen—Pancreatitis—Epirubicin—ovarian cancer	0.000138	0.000939	CcSEcCtD
Ketoprofen—Shock—Paclitaxel—ovarian cancer	0.000137	0.000937	CcSEcCtD
Ketoprofen—Dizziness—Vinorelbine—ovarian cancer	0.000137	0.000936	CcSEcCtD
Ketoprofen—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000137	0.000936	CcSEcCtD
Ketoprofen—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000137	0.000933	CcSEcCtD
Ketoprofen—Tachycardia—Paclitaxel—ovarian cancer	0.000136	0.00093	CcSEcCtD
Ketoprofen—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000135	0.000923	CcSEcCtD
Ketoprofen—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000135	0.000921	CcSEcCtD
Ketoprofen—Anaemia—Docetaxel—ovarian cancer	0.000134	0.000914	CcSEcCtD
Ketoprofen—Anorexia—Paclitaxel—ovarian cancer	0.000133	0.000908	CcSEcCtD
Ketoprofen—Gastritis—Doxorubicin—ovarian cancer	0.000133	0.000907	CcSEcCtD
Ketoprofen—Vomiting—Vinorelbine—ovarian cancer	0.000132	0.0009	CcSEcCtD
Ketoprofen—Rash—Vinorelbine—ovarian cancer	0.000131	0.000893	CcSEcCtD
Ketoprofen—Dermatitis—Vinorelbine—ovarian cancer	0.000131	0.000892	CcSEcCtD
Ketoprofen—Headache—Vinorelbine—ovarian cancer	0.00013	0.000887	CcSEcCtD
Ketoprofen—Asthma—Doxorubicin—ovarian cancer	0.00013	0.000886	CcSEcCtD
Ketoprofen—Palpitations—Docetaxel—ovarian cancer	0.000128	0.000874	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000128	0.000874	CcSEcCtD
Ketoprofen—Weight increased—Epirubicin—ovarian cancer	0.000128	0.000872	CcSEcCtD
Ketoprofen—Pancreatitis—Doxorubicin—ovarian cancer	0.000127	0.000869	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000127	0.000868	CcSEcCtD
Ketoprofen—Weight decreased—Epirubicin—ovarian cancer	0.000127	0.000866	CcSEcCtD
Ketoprofen—Insomnia—Paclitaxel—ovarian cancer	0.000126	0.000862	CcSEcCtD
Ketoprofen—Convulsion—Docetaxel—ovarian cancer	0.000126	0.000857	CcSEcCtD
Ketoprofen—Paraesthesia—Paclitaxel—ovarian cancer	0.000125	0.000855	CcSEcCtD
Ketoprofen—Hypertension—Docetaxel—ovarian cancer	0.000125	0.000854	CcSEcCtD
Ketoprofen—Drowsiness—Epirubicin—ovarian cancer	0.000125	0.000854	CcSEcCtD
Ketoprofen—Dyspnoea—Paclitaxel—ovarian cancer	0.000125	0.000849	CcSEcCtD
Ketoprofen—Somnolence—Paclitaxel—ovarian cancer	0.000124	0.000847	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000124	0.000847	CcSEcCtD
Ketoprofen—Myalgia—Docetaxel—ovarian cancer	0.000124	0.000842	CcSEcCtD
Ketoprofen—Nausea—Vinorelbine—ovarian cancer	0.000123	0.000841	CcSEcCtD
Ketoprofen—Renal failure—Epirubicin—ovarian cancer	0.000123	0.000839	CcSEcCtD
Ketoprofen—Dyspepsia—Paclitaxel—ovarian cancer	0.000123	0.000838	CcSEcCtD
Ketoprofen—Stomatitis—Epirubicin—ovarian cancer	0.000122	0.000832	CcSEcCtD
Ketoprofen—Jaundice—Epirubicin—ovarian cancer	0.000122	0.000832	CcSEcCtD
Ketoprofen—Conjunctivitis—Epirubicin—ovarian cancer	0.000122	0.00083	CcSEcCtD
Ketoprofen—Decreased appetite—Paclitaxel—ovarian cancer	0.000121	0.000828	CcSEcCtD
Ketoprofen—Dry mouth—Docetaxel—ovarian cancer	0.000121	0.000824	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000121	0.000822	CcSEcCtD
Ketoprofen—Fatigue—Paclitaxel—ovarian cancer	0.00012	0.000821	CcSEcCtD
Ketoprofen—Sweating—Epirubicin—ovarian cancer	0.00012	0.000819	CcSEcCtD
Ketoprofen—Constipation—Paclitaxel—ovarian cancer	0.000119	0.000815	CcSEcCtD
Ketoprofen—Haematuria—Epirubicin—ovarian cancer	0.000119	0.000814	CcSEcCtD
Ketoprofen—Confusional state—Docetaxel—ovarian cancer	0.000119	0.000814	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000119	0.000809	CcSEcCtD
Ketoprofen—Anaphylactic shock—Docetaxel—ovarian cancer	0.000118	0.000807	CcSEcCtD
Ketoprofen—Oedema—Docetaxel—ovarian cancer	0.000118	0.000807	CcSEcCtD
Ketoprofen—Weight increased—Doxorubicin—ovarian cancer	0.000118	0.000806	CcSEcCtD
Ketoprofen—Epistaxis—Epirubicin—ovarian cancer	0.000118	0.000805	CcSEcCtD
Ketoprofen—Infection—Docetaxel—ovarian cancer	0.000118	0.000802	CcSEcCtD
Ketoprofen—Weight decreased—Doxorubicin—ovarian cancer	0.000118	0.000802	CcSEcCtD
Ketoprofen—Agranulocytosis—Epirubicin—ovarian cancer	0.000117	0.000797	CcSEcCtD
Ketoprofen—Shock—Docetaxel—ovarian cancer	0.000116	0.000794	CcSEcCtD
Ketoprofen—Thrombocytopenia—Docetaxel—ovarian cancer	0.000116	0.000791	CcSEcCtD
Ketoprofen—Drowsiness—Doxorubicin—ovarian cancer	0.000116	0.00079	CcSEcCtD
Ketoprofen—Tachycardia—Docetaxel—ovarian cancer	0.000116	0.000788	CcSEcCtD
Ketoprofen—Feeling abnormal—Paclitaxel—ovarian cancer	0.000115	0.000785	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000115	0.000783	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000114	0.000779	CcSEcCtD
Ketoprofen—Renal failure—Doxorubicin—ovarian cancer	0.000114	0.000777	CcSEcCtD
Ketoprofen—Jaundice—Doxorubicin—ovarian cancer	0.000113	0.00077	CcSEcCtD
Ketoprofen—Stomatitis—Doxorubicin—ovarian cancer	0.000113	0.00077	CcSEcCtD
Ketoprofen—Anorexia—Docetaxel—ovarian cancer	0.000113	0.00077	CcSEcCtD
Ketoprofen—Rhinitis—Epirubicin—ovarian cancer	0.000113	0.000768	CcSEcCtD
Ketoprofen—Conjunctivitis—Doxorubicin—ovarian cancer	0.000113	0.000768	CcSEcCtD
Ketoprofen—Hepatitis—Epirubicin—ovarian cancer	0.000112	0.000767	CcSEcCtD
Ketoprofen—Pharyngitis—Epirubicin—ovarian cancer	0.000112	0.000761	CcSEcCtD
Ketoprofen—Sweating—Doxorubicin—ovarian cancer	0.000111	0.000757	CcSEcCtD
Ketoprofen—Urticaria—Paclitaxel—ovarian cancer	0.000111	0.000757	CcSEcCtD
Ketoprofen—Haematuria—Doxorubicin—ovarian cancer	0.00011	0.000753	CcSEcCtD
Ketoprofen—Abdominal pain—Paclitaxel—ovarian cancer	0.00011	0.000753	CcSEcCtD
Ketoprofen—Epistaxis—Doxorubicin—ovarian cancer	0.000109	0.000745	CcSEcCtD
Ketoprofen—Visual impairment—Epirubicin—ovarian cancer	0.000108	0.000739	CcSEcCtD
Ketoprofen—Agranulocytosis—Doxorubicin—ovarian cancer	0.000108	0.000737	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000108	0.000736	CcSEcCtD
Ketoprofen—Insomnia—Docetaxel—ovarian cancer	0.000107	0.00073	CcSEcCtD
Ketoprofen—Paraesthesia—Docetaxel—ovarian cancer	0.000106	0.000725	CcSEcCtD
Ketoprofen—Erythema multiforme—Epirubicin—ovarian cancer	0.000106	0.000725	CcSEcCtD
Ketoprofen—Dyspnoea—Docetaxel—ovarian cancer	0.000106	0.00072	CcSEcCtD
Ketoprofen—Somnolence—Docetaxel—ovarian cancer	0.000105	0.000718	CcSEcCtD
Ketoprofen—Tinnitus—Epirubicin—ovarian cancer	0.000105	0.000715	CcSEcCtD
Ketoprofen—Flushing—Epirubicin—ovarian cancer	0.000104	0.000711	CcSEcCtD
Ketoprofen—Rhinitis—Doxorubicin—ovarian cancer	0.000104	0.000711	CcSEcCtD
Ketoprofen—Dyspepsia—Docetaxel—ovarian cancer	0.000104	0.000711	CcSEcCtD
Ketoprofen—Hepatitis—Doxorubicin—ovarian cancer	0.000104	0.000709	CcSEcCtD
Ketoprofen—Pharyngitis—Doxorubicin—ovarian cancer	0.000103	0.000704	CcSEcCtD
Ketoprofen—Decreased appetite—Docetaxel—ovarian cancer	0.000103	0.000702	CcSEcCtD
Ketoprofen—Hypersensitivity—Paclitaxel—ovarian cancer	0.000103	0.000702	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000102	0.000697	CcSEcCtD
Ketoprofen—Fatigue—Docetaxel—ovarian cancer	0.000102	0.000696	CcSEcCtD
Ketoprofen—Constipation—Docetaxel—ovarian cancer	0.000101	0.00069	CcSEcCtD
Ketoprofen—Chills—Epirubicin—ovarian cancer	0.000101	0.000688	CcSEcCtD
Ketoprofen—Arrhythmia—Epirubicin—ovarian cancer	0.0001	0.000685	CcSEcCtD
Ketoprofen—Visual impairment—Doxorubicin—ovarian cancer	0.0001	0.000683	CcSEcCtD
Ketoprofen—Asthenia—Paclitaxel—ovarian cancer	0.0001	0.000683	CcSEcCtD
Ketoprofen—Alopecia—Epirubicin—ovarian cancer	9.93e-05	0.000677	CcSEcCtD
Ketoprofen—Pruritus—Paclitaxel—ovarian cancer	9.88e-05	0.000674	CcSEcCtD
Ketoprofen—Erythema multiforme—Doxorubicin—ovarian cancer	9.83e-05	0.000671	CcSEcCtD
Ketoprofen—Erythema—Epirubicin—ovarian cancer	9.79e-05	0.000667	CcSEcCtD
Ketoprofen—Feeling abnormal—Docetaxel—ovarian cancer	9.76e-05	0.000665	CcSEcCtD
Ketoprofen—Tinnitus—Doxorubicin—ovarian cancer	9.7e-05	0.000661	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Docetaxel—ovarian cancer	9.68e-05	0.00066	CcSEcCtD
Ketoprofen—Flushing—Doxorubicin—ovarian cancer	9.65e-05	0.000658	CcSEcCtD
Ketoprofen—Flatulence—Epirubicin—ovarian cancer	9.64e-05	0.000658	CcSEcCtD
Ketoprofen—Tension—Epirubicin—ovarian cancer	9.6e-05	0.000655	CcSEcCtD
Ketoprofen—Dysgeusia—Epirubicin—ovarian cancer	9.58e-05	0.000653	CcSEcCtD
Ketoprofen—Diarrhoea—Paclitaxel—ovarian cancer	9.56e-05	0.000652	CcSEcCtD
Ketoprofen—Nervousness—Epirubicin—ovarian cancer	9.5e-05	0.000648	CcSEcCtD
Ketoprofen—Abdominal pain—Docetaxel—ovarian cancer	9.36e-05	0.000638	CcSEcCtD
Ketoprofen—Chills—Doxorubicin—ovarian cancer	9.33e-05	0.000636	CcSEcCtD
Ketoprofen—Arrhythmia—Doxorubicin—ovarian cancer	9.29e-05	0.000634	CcSEcCtD
Ketoprofen—Dizziness—Paclitaxel—ovarian cancer	9.24e-05	0.00063	CcSEcCtD
Ketoprofen—Alopecia—Doxorubicin—ovarian cancer	9.19e-05	0.000627	CcSEcCtD
Ketoprofen—Ill-defined disorder—Epirubicin—ovarian cancer	9.08e-05	0.000619	CcSEcCtD
Ketoprofen—Erythema—Doxorubicin—ovarian cancer	9.05e-05	0.000617	CcSEcCtD
Ketoprofen—Anaemia—Epirubicin—ovarian cancer	9.04e-05	0.000617	CcSEcCtD
Ketoprofen—Flatulence—Doxorubicin—ovarian cancer	8.92e-05	0.000608	CcSEcCtD
Ketoprofen—Tension—Doxorubicin—ovarian cancer	8.89e-05	0.000606	CcSEcCtD
Ketoprofen—Vomiting—Paclitaxel—ovarian cancer	8.88e-05	0.000606	CcSEcCtD
Ketoprofen—Dysgeusia—Doxorubicin—ovarian cancer	8.87e-05	0.000605	CcSEcCtD
Ketoprofen—Malaise—Epirubicin—ovarian cancer	8.82e-05	0.000602	CcSEcCtD
Ketoprofen—Rash—Paclitaxel—ovarian cancer	8.81e-05	0.000601	CcSEcCtD
Ketoprofen—Dermatitis—Paclitaxel—ovarian cancer	8.8e-05	0.0006	CcSEcCtD
Ketoprofen—Nervousness—Doxorubicin—ovarian cancer	8.79e-05	0.0006	CcSEcCtD
Ketoprofen—Vertigo—Epirubicin—ovarian cancer	8.79e-05	0.000599	CcSEcCtD
Ketoprofen—Headache—Paclitaxel—ovarian cancer	8.75e-05	0.000597	CcSEcCtD
Ketoprofen—Hypersensitivity—Docetaxel—ovarian cancer	8.72e-05	0.000595	CcSEcCtD
Ketoprofen—Palpitations—Epirubicin—ovarian cancer	8.65e-05	0.00059	CcSEcCtD
Ketoprofen—Asthenia—Docetaxel—ovarian cancer	8.5e-05	0.000579	CcSEcCtD
Ketoprofen—Convulsion—Epirubicin—ovarian cancer	8.48e-05	0.000578	CcSEcCtD
Ketoprofen—Hypertension—Epirubicin—ovarian cancer	8.45e-05	0.000576	CcSEcCtD
Ketoprofen—Ill-defined disorder—Doxorubicin—ovarian cancer	8.4e-05	0.000573	CcSEcCtD
Ketoprofen—Pruritus—Docetaxel—ovarian cancer	8.38e-05	0.000571	CcSEcCtD
Ketoprofen—Anaemia—Doxorubicin—ovarian cancer	8.37e-05	0.000571	CcSEcCtD
Ketoprofen—Myalgia—Epirubicin—ovarian cancer	8.33e-05	0.000568	CcSEcCtD
Ketoprofen—Anxiety—Epirubicin—ovarian cancer	8.3e-05	0.000566	CcSEcCtD
Ketoprofen—Nausea—Paclitaxel—ovarian cancer	8.3e-05	0.000566	CcSEcCtD
Ketoprofen—Discomfort—Epirubicin—ovarian cancer	8.23e-05	0.000561	CcSEcCtD
Ketoprofen—Malaise—Doxorubicin—ovarian cancer	8.17e-05	0.000557	CcSEcCtD
Ketoprofen—Dry mouth—Epirubicin—ovarian cancer	8.15e-05	0.000556	CcSEcCtD
Ketoprofen—Vertigo—Doxorubicin—ovarian cancer	8.13e-05	0.000555	CcSEcCtD
Ketoprofen—Diarrhoea—Docetaxel—ovarian cancer	8.1e-05	0.000552	CcSEcCtD
Ketoprofen—Confusional state—Epirubicin—ovarian cancer	8.05e-05	0.000549	CcSEcCtD
Ketoprofen—Palpitations—Doxorubicin—ovarian cancer	8e-05	0.000546	CcSEcCtD
Ketoprofen—Anaphylactic shock—Epirubicin—ovarian cancer	7.99e-05	0.000545	CcSEcCtD
Ketoprofen—Oedema—Epirubicin—ovarian cancer	7.99e-05	0.000545	CcSEcCtD
Ketoprofen—Infection—Epirubicin—ovarian cancer	7.93e-05	0.000541	CcSEcCtD
Ketoprofen—Shock—Epirubicin—ovarian cancer	7.86e-05	0.000536	CcSEcCtD
Ketoprofen—Convulsion—Doxorubicin—ovarian cancer	7.85e-05	0.000535	CcSEcCtD
Ketoprofen—Dizziness—Docetaxel—ovarian cancer	7.83e-05	0.000534	CcSEcCtD
Ketoprofen—Thrombocytopenia—Epirubicin—ovarian cancer	7.82e-05	0.000533	CcSEcCtD
Ketoprofen—Hypertension—Doxorubicin—ovarian cancer	7.82e-05	0.000533	CcSEcCtD
Ketoprofen—Tachycardia—Epirubicin—ovarian cancer	7.79e-05	0.000531	CcSEcCtD
Ketoprofen—Hyperhidrosis—Epirubicin—ovarian cancer	7.72e-05	0.000526	CcSEcCtD
Ketoprofen—Myalgia—Doxorubicin—ovarian cancer	7.71e-05	0.000526	CcSEcCtD
Ketoprofen—Anxiety—Doxorubicin—ovarian cancer	7.68e-05	0.000524	CcSEcCtD
Ketoprofen—Discomfort—Doxorubicin—ovarian cancer	7.62e-05	0.000519	CcSEcCtD
Ketoprofen—Anorexia—Epirubicin—ovarian cancer	7.61e-05	0.000519	CcSEcCtD
Ketoprofen—Dry mouth—Doxorubicin—ovarian cancer	7.54e-05	0.000514	CcSEcCtD
Ketoprofen—Vomiting—Docetaxel—ovarian cancer	7.53e-05	0.000513	CcSEcCtD
Ketoprofen—Rash—Docetaxel—ovarian cancer	7.47e-05	0.000509	CcSEcCtD
Ketoprofen—Dermatitis—Docetaxel—ovarian cancer	7.46e-05	0.000509	CcSEcCtD
Ketoprofen—Confusional state—Doxorubicin—ovarian cancer	7.45e-05	0.000508	CcSEcCtD
Ketoprofen—Headache—Docetaxel—ovarian cancer	7.42e-05	0.000506	CcSEcCtD
Ketoprofen—Anaphylactic shock—Doxorubicin—ovarian cancer	7.39e-05	0.000504	CcSEcCtD
Ketoprofen—Oedema—Doxorubicin—ovarian cancer	7.39e-05	0.000504	CcSEcCtD
Ketoprofen—Infection—Doxorubicin—ovarian cancer	7.34e-05	0.000501	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Epirubicin—ovarian cancer	7.28e-05	0.000496	CcSEcCtD
Ketoprofen—Shock—Doxorubicin—ovarian cancer	7.27e-05	0.000496	CcSEcCtD
Ketoprofen—Thrombocytopenia—Doxorubicin—ovarian cancer	7.24e-05	0.000493	CcSEcCtD
Ketoprofen—Insomnia—Epirubicin—ovarian cancer	7.22e-05	0.000493	CcSEcCtD
Ketoprofen—Tachycardia—Doxorubicin—ovarian cancer	7.21e-05	0.000492	CcSEcCtD
Ketoprofen—Paraesthesia—Epirubicin—ovarian cancer	7.17e-05	0.000489	CcSEcCtD
Ketoprofen—Hyperhidrosis—Doxorubicin—ovarian cancer	7.14e-05	0.000487	CcSEcCtD
Ketoprofen—Dyspnoea—Epirubicin—ovarian cancer	7.12e-05	0.000486	CcSEcCtD
Ketoprofen—Somnolence—Epirubicin—ovarian cancer	7.1e-05	0.000484	CcSEcCtD
Ketoprofen—Anorexia—Doxorubicin—ovarian cancer	7.04e-05	0.00048	CcSEcCtD
Ketoprofen—Nausea—Docetaxel—ovarian cancer	7.03e-05	0.00048	CcSEcCtD
Ketoprofen—Dyspepsia—Epirubicin—ovarian cancer	7.03e-05	0.000479	CcSEcCtD
Ketoprofen—Decreased appetite—Epirubicin—ovarian cancer	6.94e-05	0.000473	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Epirubicin—ovarian cancer	6.9e-05	0.00047	CcSEcCtD
Ketoprofen—Fatigue—Epirubicin—ovarian cancer	6.89e-05	0.00047	CcSEcCtD
Ketoprofen—Constipation—Epirubicin—ovarian cancer	6.83e-05	0.000466	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	6.73e-05	0.000459	CcSEcCtD
Ketoprofen—Insomnia—Doxorubicin—ovarian cancer	6.68e-05	0.000456	CcSEcCtD
Ketoprofen—Paraesthesia—Doxorubicin—ovarian cancer	6.64e-05	0.000452	CcSEcCtD
Ketoprofen—Dyspnoea—Doxorubicin—ovarian cancer	6.59e-05	0.000449	CcSEcCtD
Ketoprofen—Feeling abnormal—Epirubicin—ovarian cancer	6.58e-05	0.000449	CcSEcCtD
Ketoprofen—Somnolence—Doxorubicin—ovarian cancer	6.57e-05	0.000448	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Epirubicin—ovarian cancer	6.53e-05	0.000445	CcSEcCtD
Ketoprofen—Dyspepsia—Doxorubicin—ovarian cancer	6.5e-05	0.000444	CcSEcCtD
Ketoprofen—Decreased appetite—Doxorubicin—ovarian cancer	6.42e-05	0.000438	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Doxorubicin—ovarian cancer	6.38e-05	0.000435	CcSEcCtD
Ketoprofen—Fatigue—Doxorubicin—ovarian cancer	6.37e-05	0.000434	CcSEcCtD
Ketoprofen—Urticaria—Epirubicin—ovarian cancer	6.34e-05	0.000433	CcSEcCtD
Ketoprofen—Constipation—Doxorubicin—ovarian cancer	6.32e-05	0.000431	CcSEcCtD
Ketoprofen—Abdominal pain—Epirubicin—ovarian cancer	6.31e-05	0.00043	CcSEcCtD
Ketoprofen—Feeling abnormal—Doxorubicin—ovarian cancer	6.09e-05	0.000415	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Doxorubicin—ovarian cancer	6.04e-05	0.000412	CcSEcCtD
Ketoprofen—Hypersensitivity—Epirubicin—ovarian cancer	5.88e-05	0.000401	CcSEcCtD
Ketoprofen—Urticaria—Doxorubicin—ovarian cancer	5.87e-05	0.0004	CcSEcCtD
Ketoprofen—Abdominal pain—Doxorubicin—ovarian cancer	5.84e-05	0.000398	CcSEcCtD
Ketoprofen—Asthenia—Epirubicin—ovarian cancer	5.73e-05	0.000391	CcSEcCtD
Ketoprofen—Pruritus—Epirubicin—ovarian cancer	5.65e-05	0.000385	CcSEcCtD
Ketoprofen—Diarrhoea—Epirubicin—ovarian cancer	5.46e-05	0.000373	CcSEcCtD
Ketoprofen—Hypersensitivity—Doxorubicin—ovarian cancer	5.44e-05	0.000371	CcSEcCtD
Ketoprofen—Asthenia—Doxorubicin—ovarian cancer	5.3e-05	0.000362	CcSEcCtD
Ketoprofen—Dizziness—Epirubicin—ovarian cancer	5.28e-05	0.00036	CcSEcCtD
Ketoprofen—Pruritus—Doxorubicin—ovarian cancer	5.23e-05	0.000356	CcSEcCtD
Ketoprofen—Vomiting—Epirubicin—ovarian cancer	5.08e-05	0.000346	CcSEcCtD
Ketoprofen—Diarrhoea—Doxorubicin—ovarian cancer	5.06e-05	0.000345	CcSEcCtD
Ketoprofen—Rash—Epirubicin—ovarian cancer	5.04e-05	0.000343	CcSEcCtD
Ketoprofen—Dermatitis—Epirubicin—ovarian cancer	5.03e-05	0.000343	CcSEcCtD
Ketoprofen—Headache—Epirubicin—ovarian cancer	5e-05	0.000341	CcSEcCtD
Ketoprofen—Dizziness—Doxorubicin—ovarian cancer	4.89e-05	0.000333	CcSEcCtD
Ketoprofen—Nausea—Epirubicin—ovarian cancer	4.74e-05	0.000323	CcSEcCtD
Ketoprofen—Vomiting—Doxorubicin—ovarian cancer	4.7e-05	0.00032	CcSEcCtD
Ketoprofen—Rash—Doxorubicin—ovarian cancer	4.66e-05	0.000318	CcSEcCtD
Ketoprofen—Dermatitis—Doxorubicin—ovarian cancer	4.66e-05	0.000317	CcSEcCtD
Ketoprofen—Headache—Doxorubicin—ovarian cancer	4.63e-05	0.000316	CcSEcCtD
Ketoprofen—Nausea—Doxorubicin—ovarian cancer	4.39e-05	0.000299	CcSEcCtD
Ketoprofen—CXCL8—Signaling by GPCR—PIK3CD—ovarian cancer	1.74e-05	0.000312	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.73e-05	0.00031	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MMP9—ovarian cancer	1.72e-05	0.000309	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—PTEN—ovarian cancer	1.71e-05	0.000307	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CYP1B1—ovarian cancer	1.7e-05	0.000306	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PPP1CC—ovarian cancer	1.68e-05	0.000302	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—BRIP1—ovarian cancer	1.68e-05	0.000302	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.68e-05	0.000302	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PPP1CC—ovarian cancer	1.67e-05	0.0003	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—BRIP1—ovarian cancer	1.67e-05	0.0003	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.67e-05	0.0003	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—AKT1—ovarian cancer	1.67e-05	0.0003	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—PIK3CB—ovarian cancer	1.67e-05	0.000299	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	1.66e-05	0.000299	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—XIAP—ovarian cancer	1.62e-05	0.000291	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—VEGFA—ovarian cancer	1.61e-05	0.000289	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—NRAS—ovarian cancer	1.59e-05	0.000286	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SMARCA4—ovarian cancer	1.58e-05	0.000284	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYTB—ovarian cancer	1.57e-05	0.000281	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—VEGFA—ovarian cancer	1.55e-05	0.000277	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—EREG—ovarian cancer	1.54e-05	0.000277	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.53e-05	0.000275	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.53e-05	0.000275	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—STAT3—ovarian cancer	1.53e-05	0.000275	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—IL2—ovarian cancer	1.53e-05	0.000275	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—NRAS—ovarian cancer	1.53e-05	0.000274	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—MAPK3—ovarian cancer	1.52e-05	0.000274	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.52e-05	0.000273	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—PIK3CB—ovarian cancer	1.51e-05	0.000272	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PPP2R1A—ovarian cancer	1.51e-05	0.000271	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.51e-05	0.00027	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.5e-05	0.00027	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.48e-05	0.000266	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.46e-05	0.000263	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MAPK3—ovarian cancer	1.46e-05	0.000262	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—MAPK1—ovarian cancer	1.45e-05	0.00026	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—FASN—ovarian cancer	1.42e-05	0.000256	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MYC—ovarian cancer	1.42e-05	0.000255	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	1.41e-05	0.000254	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—ABCB1—ovarian cancer	1.4e-05	0.000252	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—SLC5A5—ovarian cancer	1.4e-05	0.000251	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MAPK1—ovarian cancer	1.39e-05	0.00025	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—EGFR—ovarian cancer	1.39e-05	0.00025	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—IL2—ovarian cancer	1.39e-05	0.000249	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—YAP1—ovarian cancer	1.39e-05	0.000249	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TERT—ovarian cancer	1.38e-05	0.000248	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—TYMS—ovarian cancer	1.38e-05	0.000247	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.37e-05	0.000246	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—KRAS—ovarian cancer	1.37e-05	0.000246	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.37e-05	0.000246	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.37e-05	0.000246	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—SLC2A1—ovarian cancer	1.35e-05	0.000243	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—FASN—ovarian cancer	1.35e-05	0.000242	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PARP1—ovarian cancer	1.34e-05	0.000241	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—CAV1—ovarian cancer	1.34e-05	0.00024	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	1.34e-05	0.00024	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.32e-05	0.000238	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—KRAS—ovarian cancer	1.31e-05	0.000236	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CYP1B1—ovarian cancer	1.3e-05	0.000233	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SLC2A1—ovarian cancer	1.28e-05	0.00023	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CAV1—ovarian cancer	1.28e-05	0.00023	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	1.27e-05	0.000229	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—PIK3CA—ovarian cancer	1.26e-05	0.000226	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.25e-05	0.000225	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ESR1—ovarian cancer	1.23e-05	0.000221	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.23e-05	0.00022	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PIK3CG—ovarian cancer	1.22e-05	0.000219	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.22e-05	0.000219	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TP53—ovarian cancer	1.22e-05	0.000219	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IL6ST—ovarian cancer	1.21e-05	0.000218	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—PIK3CA—ovarian cancer	1.21e-05	0.000217	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.21e-05	0.000216	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TP53—ovarian cancer	1.17e-05	0.00021	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PIK3CG—ovarian cancer	1.17e-05	0.000209	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—APC—ovarian cancer	1.17e-05	0.000209	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—NRAS—ovarian cancer	1.17e-05	0.000209	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—HRAS—ovarian cancer	1.16e-05	0.000209	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PPP2R1A—ovarian cancer	1.15e-05	0.000206	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.14e-05	0.000205	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—FASN—ovarian cancer	1.13e-05	0.000203	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—YAP1—ovarian cancer	1.13e-05	0.000202	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—YAP1—ovarian cancer	1.12e-05	0.000201	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—MAPK3—ovarian cancer	1.12e-05	0.0002	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—HRAS—ovarian cancer	1.12e-05	0.0002	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.12e-05	0.0002	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—SLC5A5—ovarian cancer	1.11e-05	0.0002	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CAV1—ovarian cancer	1.11e-05	0.000199	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.11e-05	0.000199	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	1.11e-05	0.000198	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PPP2R1A—ovarian cancer	1.09e-05	0.000196	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—SLC2A1—ovarian cancer	1.07e-05	0.000193	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PIK3CD—ovarian cancer	1.07e-05	0.000192	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—IL6—ovarian cancer	1.07e-05	0.000192	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ABCB1—ovarian cancer	1.07e-05	0.000192	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—MAPK1—ovarian cancer	1.06e-05	0.000191	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—EGFR—ovarian cancer	1.06e-05	0.000191	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.06e-05	0.00019	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.05e-05	0.000189	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—TYMS—ovarian cancer	1.05e-05	0.000188	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CYP1B1—ovarian cancer	1.03e-05	0.000185	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—AKT1—ovarian cancer	1.03e-05	0.000185	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PIK3CD—ovarian cancer	1.03e-05	0.000184	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—PIK3CA—ovarian cancer	1.02e-05	0.000182	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PIK3CG—ovarian cancer	1.01e-05	0.000182	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—KRAS—ovarian cancer	1e-05	0.00018	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.98e-06	0.000179	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—AKT1—ovarian cancer	9.86e-06	0.000177	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.82e-06	0.000176	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.76e-06	0.000175	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PIK3CB—ovarian cancer	9.34e-06	0.000168	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—PIK3CA—ovarian cancer	9.22e-06	0.000166	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—FASN—ovarian cancer	9.2e-06	0.000165	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—YAP1—ovarian cancer	9.18e-06	0.000165	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—FASN—ovarian cancer	9.14e-06	0.000164	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PPP2R1A—ovarian cancer	9.13e-06	0.000164	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.09e-06	0.000163	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	9.09e-06	0.000163	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ERBB2—ovarian cancer	9.06e-06	0.000163	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SLC5A5—ovarian cancer	9.05e-06	0.000162	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	9.03e-06	0.000162	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SLC5A5—ovarian cancer	9e-06	0.000161	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PIK3CB—ovarian cancer	8.94e-06	0.00016	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MTOR—ovarian cancer	8.94e-06	0.00016	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PIK3CD—ovarian cancer	8.9e-06	0.00016	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SLC2A1—ovarian cancer	8.74e-06	0.000157	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SLC2A1—ovarian cancer	8.69e-06	0.000156	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TERT—ovarian cancer	8.66e-06	0.000155	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IL2—ovarian cancer	8.58e-06	0.000154	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.56e-06	0.000154	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—HRAS—ovarian cancer	8.53e-06	0.000153	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.51e-06	0.000153	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ABCB1—ovarian cancer	8.48e-06	0.000152	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CAV1—ovarian cancer	8.45e-06	0.000152	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CDKN1B—ovarian cancer	8.39e-06	0.000151	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CYP1B1—ovarian cancer	8.38e-06	0.00015	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CYP1B1—ovarian cancer	8.33e-06	0.000149	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—TYMS—ovarian cancer	8.33e-06	0.000149	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—AKT1—ovarian cancer	8.3e-06	0.000149	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CASP3—ovarian cancer	8.22e-06	0.000148	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IL2—ovarian cancer	8.21e-06	0.000147	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—IL6—ovarian cancer	8.17e-06	0.000147	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.07e-06	0.000145	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CAV1—ovarian cancer	8.01e-06	0.000144	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCND1—ovarian cancer	8e-06	0.000144	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.99e-06	0.000143	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CTNNB1—ovarian cancer	7.92e-06	0.000142	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MMP9—ovarian cancer	7.77e-06	0.000139	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PIK3CB—ovarian cancer	7.75e-06	0.000139	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PTEN—ovarian cancer	7.72e-06	0.000139	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PIK3CG—ovarian cancer	7.7e-06	0.000138	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—IL6ST—ovarian cancer	7.59e-06	0.000136	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—AKT1—ovarian cancer	7.54e-06	0.000135	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—FASN—ovarian cancer	7.49e-06	0.000134	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	7.43e-06	0.000133	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.39e-06	0.000133	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PPP2R1A—ovarian cancer	7.39e-06	0.000133	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SLC5A5—ovarian cancer	7.36e-06	0.000132	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.35e-06	0.000132	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—APC—ovarian cancer	7.3e-06	0.000131	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—VEGFA—ovarian cancer	7.29e-06	0.000131	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—NRAS—ovarian cancer	7.2e-06	0.000129	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SLC2A1—ovarian cancer	7.11e-06	0.000128	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—VEGFA—ovarian cancer	6.98e-06	0.000125	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.96e-06	0.000125	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—STAT3—ovarian cancer	6.91e-06	0.000124	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—MAPK3—ovarian cancer	6.9e-06	0.000124	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ABCB1—ovarian cancer	6.9e-06	0.000124	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NRAS—ovarian cancer	6.89e-06	0.000124	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ABCB1—ovarian cancer	6.86e-06	0.000123	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYP1B1—ovarian cancer	6.82e-06	0.000122	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—TYMS—ovarian cancer	6.77e-06	0.000122	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PIK3CD—ovarian cancer	6.77e-06	0.000121	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—TYMS—ovarian cancer	6.74e-06	0.000121	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CAV1—ovarian cancer	6.71e-06	0.00012	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTEN—ovarian cancer	6.7e-06	0.00012	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MAPK3—ovarian cancer	6.6e-06	0.000118	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—MAPK1—ovarian cancer	6.56e-06	0.000118	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MYC—ovarian cancer	6.42e-06	0.000115	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PIK3CD—ovarian cancer	6.41e-06	0.000115	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.41e-06	0.000115	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MAPK1—ovarian cancer	6.28e-06	0.000113	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EGFR—ovarian cancer	6.28e-06	0.000113	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—KRAS—ovarian cancer	6.2e-06	0.000111	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PIK3CG—ovarian cancer	6.11e-06	0.00011	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	6.05e-06	0.000109	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.02e-06	0.000108	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KRAS—ovarian cancer	5.93e-06	0.000106	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PIK3CB—ovarian cancer	5.9e-06	0.000106	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PIK3CA—ovarian cancer	5.7e-06	0.000102	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ERBB2—ovarian cancer	5.67e-06	0.000102	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ABCB1—ovarian cancer	5.61e-06	0.000101	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PIK3CB—ovarian cancer	5.59e-06	0.0001	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MTOR—ovarian cancer	5.59e-06	0.0001	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—TYMS—ovarian cancer	5.51e-06	9.89e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TP53—ovarian cancer	5.51e-06	9.89e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CAV1—ovarian cancer	5.46e-06	9.8e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PIK3CA—ovarian cancer	5.45e-06	9.78e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CAV1—ovarian cancer	5.43e-06	9.74e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PIK3CD—ovarian cancer	5.37e-06	9.64e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TP53—ovarian cancer	5.27e-06	9.46e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—HRAS—ovarian cancer	5.27e-06	9.46e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CDKN1B—ovarian cancer	5.25e-06	9.42e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.22e-06	9.36e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.19e-06	9.31e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PTEN—ovarian cancer	5.1e-06	9.15e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HRAS—ovarian cancer	5.04e-06	9.05e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PIK3CG—ovarian cancer	4.97e-06	8.92e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CTNNB1—ovarian cancer	4.96e-06	8.9e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PIK3CG—ovarian cancer	4.94e-06	8.87e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PTEN—ovarian cancer	4.83e-06	8.67e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IL6—ovarian cancer	4.82e-06	8.66e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PIK3CA—ovarian cancer	4.73e-06	8.48e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PIK3CB—ovarian cancer	4.68e-06	8.4e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—AKT1—ovarian cancer	4.65e-06	8.35e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—AKT1—ovarian cancer	4.45e-06	7.99e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CAV1—ovarian cancer	4.44e-06	7.97e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PIK3CD—ovarian cancer	4.37e-06	7.84e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PIK3CD—ovarian cancer	4.35e-06	7.8e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—STAT3—ovarian cancer	4.32e-06	7.75e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NRAS—ovarian cancer	4.31e-06	7.74e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.24e-06	7.62e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MAPK3—ovarian cancer	4.13e-06	7.41e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PIK3CG—ovarian cancer	4.05e-06	7.26e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PTEN—ovarian cancer	4.05e-06	7.26e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MYC—ovarian cancer	4.02e-06	7.21e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MAPK1—ovarian cancer	3.93e-06	7.05e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—EGFR—ovarian cancer	3.93e-06	7.05e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—AKT1—ovarian cancer	3.86e-06	6.93e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PIK3CB—ovarian cancer	3.81e-06	6.84e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PIK3CB—ovarian cancer	3.79e-06	6.8e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—KRAS—ovarian cancer	3.71e-06	6.66e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PIK3CA—ovarian cancer	3.6e-06	6.45e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PIK3CD—ovarian cancer	3.56e-06	6.38e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PIK3CA—ovarian cancer	3.41e-06	6.12e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTEN—ovarian cancer	3.29e-06	5.91e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTEN—ovarian cancer	3.27e-06	5.87e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HRAS—ovarian cancer	3.15e-06	5.66e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PIK3CB—ovarian cancer	3.1e-06	5.56e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—IL6—ovarian cancer	3.02e-06	5.42e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—AKT1—ovarian cancer	2.94e-06	5.27e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PIK3CA—ovarian cancer	2.85e-06	5.12e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—AKT1—ovarian cancer	2.78e-06	5e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTEN—ovarian cancer	2.68e-06	4.81e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—AKT1—ovarian cancer	2.33e-06	4.18e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PIK3CA—ovarian cancer	2.32e-06	4.17e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PIK3CA—ovarian cancer	2.31e-06	4.14e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—AKT1—ovarian cancer	1.9e-06	3.4e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.89e-06	3.39e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—AKT1—ovarian cancer	1.89e-06	3.39e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—AKT1—ovarian cancer	1.54e-06	2.77e-05	CbGpPWpGaD
